Home New Customer? Create Account
Member Login:

In Vivo Magnetofection

IV-KC30230 - In vivo ViroMag Starter Kit

PRICE

Starting at: $416.00

Please Choose:

Shipping Option



Enter Quantity:
This kit includes in vivo ViroMag™ Transduction Reagent and a magnet set.

In vivo ViroMag™ Transduction Reagent is an optimized nanoparticles formulation designed for in vivo targeted transduction with viral vectors. It is particularly suitable for Lentiviral/Retroviral, Adenoviral and Adeno-Associated Viral (AAV) vectors. 

Targeted delivery minimizes systemic distribution, decreases gene vectors inactivation and reduces toxicity. The use of magnetic forces enhances the uptake of magnetic nanoparticles by the target tissue, improving the efficiency of transduction and decreasing the required process time of delivery to only a few minutes. In vivo ViroMag™ can be easily administrated through both systemic administration, such as intravenous and intra-artery injection, and local administration, such as intratumoral, intracerebroventricular, intraperitoneal, intramuscular and subcutaneous injection. 


Figure 1: High efficiency of in vivo ViroMag for targeting viral vector after intracerebroventricular injection. Third ventricles of in utero rat embryos were injected with GFP-encoding viral particles alone or complexed to in vivo ViroMag. Without magnetic nanoparticles (A), the virus-transduced cells are located on both sides of the ventricle. Using in vivoViroMag (B), transduction is enhanced and confined to one side due to a 30s magnet-application.



Figure 2: Infection of rat embryo brain. Brain sections at 8 days after lateral ventricular injection of 109 particles of GFP-lentivirus coupled with in vivo ViroMag into in utero rat embryos (E16) showed a diffuse GFP expression (in green) due to a widespread infection of neurons (A). The association of GFP-lentivirus with ViroMag induced a targeted local area as shown by the GFP expression in neurons lying under a magnet at the surface of the embryo skull (B). A more intense and restricted GFP-expression (C) was also observed when the magnet was positioned on the edge of the brain leading to an accumulation of viral particles and infected neurons in the focal area.

Figure 3: The magnet set includes 1 extra small cylinder magnet (2mm diameter), 1 small cylinder magnet (5mm diameter), 1 cylinder magnet (10mm diameter) and 1 square magnet (18 x 18mm).

Features

  • Specialized for viral vectors
  • Increases transduction efficiency
  • Reduces required virus doses and systemic dissemination
  • Can be used under non-permissive conditions such as hypothermia and physiological flow conditions
  • Minimizes toxicity
  • Can be applied through systemic administration or local administration
  • Can be used with all viruses

Applications

  • In vivo targeted transduction with viral vectors

Contents

  • in vivo ViroMag™ Transduction Reagent, 250 µl
  • Magnet set - 1 extra small cylinder (2mm diameter), 1 small cylinder (5mm diameter), 1 cylinder (10mm diameter) and 1 square (18 x 18mm)